| . | All procedures (N = 54) . | Coherence (N = 27) . | No coherence (N = 27) . | P-value . |
|---|---|---|---|---|
| Median age (IQR) (years) | 35 (30–48) | 35 (31–54) | 37 (29–48) | 0.76 |
| Median body weight (IQR) (kg) | 80 (66–93) | 80 (64–99) | 79 (67–92) | 0.67 |
| Number complex CHD (%) | 27 (50%) | 19 (70%) | 8 (30%) | 0.006 |
| Intracardial PM/ICD | 21 (39%) | 12 (44%) | 9 (33%) | 0.40 |
| AAM before ablation | 41 (75%) | 19 (70%) | 22 (81%) | 0.34 |
| Number of primary procedures | 42 (78%) | 22 (81%) | 20 (74%) | 0.37 |
| Median fluoroscopy time (IQR) (min) | 10 (5.2–14) | 12 (4–15) | 9 (7,3−0.3) | 0.84 |
| Median procedure duration (IQR) (min) | 180 (120–214) | 180 (150–240) | 150 (120–210) | 0.047 |
| Tachycardia mechanism | ||||
| ȃIART | 50 (78%) | 25 (86%) | 25 (71%) | 0.31a |
| ȃȃIART CTI dependent | ȃȃ21 (42%) | ȃȃ14 (56%) | ȃȃ7 (28%) | 0.12b |
| ȃȃIART non-CTI-dependent | ȃȃ29 (58%) | ȃȃ11 (44%) | ȃȃ18 (72%) | |
| ȃFAT | 14 (22%) | 4 (14%) | 10 (29%) | |
| Atrial fibrillation | 13 (24%) | 9 (33%) | 4 (15%) | 0.11 |
| Ablation | ||||
| ȃSVA only | 24 (44%) | 10 (37%) | 14 (58%) | 0.5 |
| ȃPVA only | 12 (22%) | 7 (26%) | 5 (19%) | |
| ȃSVA and PVA | 18 (33%) | 10 (37%) | 8 (30%) | |
| ȃCTI (SVA/PVA) | 30 (56%) | 18 (67%) | 12 (44%) | 0.1 |
| ȃPVI | 10 (19%) | 4 (15%) | 6 (22%) | 0.48 |
| Ablation time (IQR) (s) | 1035 (598–1936) | 1380 (600–1929) | 899 (591–1957) | 0.59 |
| Success | 47/54 (87%) | 27/27 (100%) | 20 (74%) | 0.01 |
| AAM after ablation | 37 (68%) | 16 (59%) | 21 (78%) | 0.14 |
| . | All procedures (N = 54) . | Coherence (N = 27) . | No coherence (N = 27) . | P-value . |
|---|---|---|---|---|
| Median age (IQR) (years) | 35 (30–48) | 35 (31–54) | 37 (29–48) | 0.76 |
| Median body weight (IQR) (kg) | 80 (66–93) | 80 (64–99) | 79 (67–92) | 0.67 |
| Number complex CHD (%) | 27 (50%) | 19 (70%) | 8 (30%) | 0.006 |
| Intracardial PM/ICD | 21 (39%) | 12 (44%) | 9 (33%) | 0.40 |
| AAM before ablation | 41 (75%) | 19 (70%) | 22 (81%) | 0.34 |
| Number of primary procedures | 42 (78%) | 22 (81%) | 20 (74%) | 0.37 |
| Median fluoroscopy time (IQR) (min) | 10 (5.2–14) | 12 (4–15) | 9 (7,3−0.3) | 0.84 |
| Median procedure duration (IQR) (min) | 180 (120–214) | 180 (150–240) | 150 (120–210) | 0.047 |
| Tachycardia mechanism | ||||
| ȃIART | 50 (78%) | 25 (86%) | 25 (71%) | 0.31a |
| ȃȃIART CTI dependent | ȃȃ21 (42%) | ȃȃ14 (56%) | ȃȃ7 (28%) | 0.12b |
| ȃȃIART non-CTI-dependent | ȃȃ29 (58%) | ȃȃ11 (44%) | ȃȃ18 (72%) | |
| ȃFAT | 14 (22%) | 4 (14%) | 10 (29%) | |
| Atrial fibrillation | 13 (24%) | 9 (33%) | 4 (15%) | 0.11 |
| Ablation | ||||
| ȃSVA only | 24 (44%) | 10 (37%) | 14 (58%) | 0.5 |
| ȃPVA only | 12 (22%) | 7 (26%) | 5 (19%) | |
| ȃSVA and PVA | 18 (33%) | 10 (37%) | 8 (30%) | |
| ȃCTI (SVA/PVA) | 30 (56%) | 18 (67%) | 12 (44%) | 0.1 |
| ȃPVI | 10 (19%) | 4 (15%) | 6 (22%) | 0.48 |
| Ablation time (IQR) (s) | 1035 (598–1936) | 1380 (600–1929) | 899 (591–1957) | 0.59 |
| Success | 47/54 (87%) | 27/27 (100%) | 20 (74%) | 0.01 |
| AAM after ablation | 37 (68%) | 16 (59%) | 21 (78%) | 0.14 |
AAM, antiarrhythmic medication; CHD, congenital heart defect; CTI, cavotricuspid isthmus; FAT, focal atrial tachycardia; IART, intraatrial re-entrant tachycardia; IQR, interquartile range; PVA, pulmonary venous atrium; PVI, pulmonary vein isolation; SVA, systemic venous atrium.
Comparison between IART and FAT.
Comparison between IART CTI dependent and IART non-CTI dependent.
The bold values are significant as statistical significance was given at a level of P < 0.05 as indicated in the section Statistical Analysis.
| . | All procedures (N = 54) . | Coherence (N = 27) . | No coherence (N = 27) . | P-value . |
|---|---|---|---|---|
| Median age (IQR) (years) | 35 (30–48) | 35 (31–54) | 37 (29–48) | 0.76 |
| Median body weight (IQR) (kg) | 80 (66–93) | 80 (64–99) | 79 (67–92) | 0.67 |
| Number complex CHD (%) | 27 (50%) | 19 (70%) | 8 (30%) | 0.006 |
| Intracardial PM/ICD | 21 (39%) | 12 (44%) | 9 (33%) | 0.40 |
| AAM before ablation | 41 (75%) | 19 (70%) | 22 (81%) | 0.34 |
| Number of primary procedures | 42 (78%) | 22 (81%) | 20 (74%) | 0.37 |
| Median fluoroscopy time (IQR) (min) | 10 (5.2–14) | 12 (4–15) | 9 (7,3−0.3) | 0.84 |
| Median procedure duration (IQR) (min) | 180 (120–214) | 180 (150–240) | 150 (120–210) | 0.047 |
| Tachycardia mechanism | ||||
| ȃIART | 50 (78%) | 25 (86%) | 25 (71%) | 0.31a |
| ȃȃIART CTI dependent | ȃȃ21 (42%) | ȃȃ14 (56%) | ȃȃ7 (28%) | 0.12b |
| ȃȃIART non-CTI-dependent | ȃȃ29 (58%) | ȃȃ11 (44%) | ȃȃ18 (72%) | |
| ȃFAT | 14 (22%) | 4 (14%) | 10 (29%) | |
| Atrial fibrillation | 13 (24%) | 9 (33%) | 4 (15%) | 0.11 |
| Ablation | ||||
| ȃSVA only | 24 (44%) | 10 (37%) | 14 (58%) | 0.5 |
| ȃPVA only | 12 (22%) | 7 (26%) | 5 (19%) | |
| ȃSVA and PVA | 18 (33%) | 10 (37%) | 8 (30%) | |
| ȃCTI (SVA/PVA) | 30 (56%) | 18 (67%) | 12 (44%) | 0.1 |
| ȃPVI | 10 (19%) | 4 (15%) | 6 (22%) | 0.48 |
| Ablation time (IQR) (s) | 1035 (598–1936) | 1380 (600–1929) | 899 (591–1957) | 0.59 |
| Success | 47/54 (87%) | 27/27 (100%) | 20 (74%) | 0.01 |
| AAM after ablation | 37 (68%) | 16 (59%) | 21 (78%) | 0.14 |
| . | All procedures (N = 54) . | Coherence (N = 27) . | No coherence (N = 27) . | P-value . |
|---|---|---|---|---|
| Median age (IQR) (years) | 35 (30–48) | 35 (31–54) | 37 (29–48) | 0.76 |
| Median body weight (IQR) (kg) | 80 (66–93) | 80 (64–99) | 79 (67–92) | 0.67 |
| Number complex CHD (%) | 27 (50%) | 19 (70%) | 8 (30%) | 0.006 |
| Intracardial PM/ICD | 21 (39%) | 12 (44%) | 9 (33%) | 0.40 |
| AAM before ablation | 41 (75%) | 19 (70%) | 22 (81%) | 0.34 |
| Number of primary procedures | 42 (78%) | 22 (81%) | 20 (74%) | 0.37 |
| Median fluoroscopy time (IQR) (min) | 10 (5.2–14) | 12 (4–15) | 9 (7,3−0.3) | 0.84 |
| Median procedure duration (IQR) (min) | 180 (120–214) | 180 (150–240) | 150 (120–210) | 0.047 |
| Tachycardia mechanism | ||||
| ȃIART | 50 (78%) | 25 (86%) | 25 (71%) | 0.31a |
| ȃȃIART CTI dependent | ȃȃ21 (42%) | ȃȃ14 (56%) | ȃȃ7 (28%) | 0.12b |
| ȃȃIART non-CTI-dependent | ȃȃ29 (58%) | ȃȃ11 (44%) | ȃȃ18 (72%) | |
| ȃFAT | 14 (22%) | 4 (14%) | 10 (29%) | |
| Atrial fibrillation | 13 (24%) | 9 (33%) | 4 (15%) | 0.11 |
| Ablation | ||||
| ȃSVA only | 24 (44%) | 10 (37%) | 14 (58%) | 0.5 |
| ȃPVA only | 12 (22%) | 7 (26%) | 5 (19%) | |
| ȃSVA and PVA | 18 (33%) | 10 (37%) | 8 (30%) | |
| ȃCTI (SVA/PVA) | 30 (56%) | 18 (67%) | 12 (44%) | 0.1 |
| ȃPVI | 10 (19%) | 4 (15%) | 6 (22%) | 0.48 |
| Ablation time (IQR) (s) | 1035 (598–1936) | 1380 (600–1929) | 899 (591–1957) | 0.59 |
| Success | 47/54 (87%) | 27/27 (100%) | 20 (74%) | 0.01 |
| AAM after ablation | 37 (68%) | 16 (59%) | 21 (78%) | 0.14 |
AAM, antiarrhythmic medication; CHD, congenital heart defect; CTI, cavotricuspid isthmus; FAT, focal atrial tachycardia; IART, intraatrial re-entrant tachycardia; IQR, interquartile range; PVA, pulmonary venous atrium; PVI, pulmonary vein isolation; SVA, systemic venous atrium.
Comparison between IART and FAT.
Comparison between IART CTI dependent and IART non-CTI dependent.
The bold values are significant as statistical significance was given at a level of P < 0.05 as indicated in the section Statistical Analysis.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
